S
Superbranche
Biotech nanoparticles transforming cancer diagnosis and treatment
About Superbranche
SuperBranche is an innovative biotech startup that specializes in developing advanced nanoparticles for the diagnosis and treatment of cancer tumors. Founded by Emmanuel Bertomeu, the company has spent over a decade in interdisciplinary research and development (R&D) to create cutting-edge solutions that significantly improve cancer care. SuperBranche's technology not only aids in the initial diagnosis of cancer but also enhances the ongoing monitoring and treatment of cancer cells, making it a comprehensive tool in the fight against this disease.
The company primarily serves healthcare providers, including hospitals, clinics, and research institutions, that are focused on oncology. By offering a more precise and efficient method for diagnosing and treating cancer, SuperBranche aims to improve patient outcomes and reduce the overall cost of cancer care.
SuperBranche operates in the biotech and healthcare market, which is a rapidly growing sector driven by advancements in medical technology and an increasing global focus on improving healthcare outcomes. The company's business model revolves around the development and commercialization of its proprietary nanoparticle technology. It generates revenue through the sale of its diagnostic and therapeutic products to healthcare providers and through partnerships with other biotech firms and research institutions.
Additionally, SuperBranche has garnered significant recognition in the industry, including winning the prestigious Grand Prix du Jury at the 2019 i-Lab Competition. This accolade underscores the company's innovative approach and the potential impact of its technology on cancer treatment.
In summary, SuperBranche is a pioneering biotech firm dedicated to revolutionizing cancer diagnosis and treatment through its advanced nanoparticle technology. It serves healthcare providers in the oncology sector and operates on a business model focused on product sales and strategic partnerships.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Strasbourg, France
- Employees
- 20
- Open positions
- None listed
- Dealroom signal
- 88.9/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, biotech medtech and e-health, Observatoire Deeptech, Techbio, Woman Founder, participations bpifrance, observatoire industrial tech
- Technology
- Deep Tech, Nanotech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Feb 2025 | $14M | $57M | Capital Grand Est · Bpifrance | ↗ |
| SEED✓Equity / VC | Nov 2020 | $440K | $1.8M | Alsace Business Angels · Bpifrance · Finck Ventures | ↗ |
Growth signals
Latest recorded traffic for Superbranche is 280 monthly website visits, down 6.7% over the last three months. Superbranche's team grew 33.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Alsace Business Angels
Bpifrance
Finck Ventures
Series A1 investor entered at this stage
Capital Grand Est
Other known investors5 additional known investors
CNRS Innovation
French National Centre for Scientific Research - CNRS
University of Strasbourg
Critical Path Ventures
SEMIA
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Superbranche on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Superbranche’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.